Crocs director Douglas J. Treff sells 14,802 shares

Q: How many CROX shares did director Douglas J. Treff sell?

Douglas J. Treff reported sales totaling 14,802 shares on November 2, 2026, across four transactions: 3,416 shares, 3,101 shares, 7,185 shares, and 1,100 shares.

Q: What price ranges applied to Douglas J. Treff’s CROX sales?

The reported weighted-average prices were $150.7006, $151.8064, $152.8515, and $153.7014 per share. The respective transaction-price ranges were $150.26–$151.19, $151.31–$152.24, $152.43–$153.25, and $153.63–$153.85.

Footnotes report that each listed price is a weighted average of multiple sales and specify a separate execution range for each transaction.

Available on EDGAR 11/04/2026 - 04:46 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:45 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Crocs, Inc. director Douglas J. Treff reported four direct sales of Common Stock on November 2, 2026, totaling 14,802 shares. The reported weighted-average prices were $150.7006 for 3,416 shares, $151.8064 for 3,101 shares, $152.8515 for 7,185 shares, and $153.7014 for 1,100 shares. Footnotes specify a separate transaction-price range for each sale. The Form 4 does not report a Rule 10b5-1 plan.

Insider Trade Summary

Net Seller: 14,802 shares

Net Sell 4 txns

Insider TREFF DOUGLAS J

Role Director

Sold 14,802 shs ($2.25M)

Share of Position Sold 17.0%

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	3,416	$150.7006	$515K
Sale	Common Stock ^F2	3,101	$151.8064	$471K
Sale	Common Stock ^F3	7,185	$152.8515	$1.10M
Sale	Common Stock ^F4	1,100	$153.7014	$169K

Holdings After Transaction: Common Stock — 72,085 shares (Direct)

Holdings Before and After: Common Stock, 86,887 to 72,085 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

F1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.26 - $151.19, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.
F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.31 to $152.24, inclusive.
F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.43 to $153.25, inclusive
F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.63 to $153.85, inclusive.

Key Figures

Shares sold: 3,416 shares Weighted-average sale price: $150.7006 per share Shares sold: 3,101 shares +5 more

8 metrics

Shares sold 3,416 shares Sale on November 2, 2026

Weighted-average sale price $150.7006 per share Sale of 3,416 shares on November 2, 2026

Shares sold 3,101 shares Sale on November 2, 2026

Weighted-average sale price $151.8064 per share Sale of 3,101 shares on November 2, 2026

Shares sold 7,185 shares Sale on November 2, 2026

Weighted-average sale price $152.8515 per share Sale of 7,185 shares on November 2, 2026

Shares sold 1,100 shares Sale on November 2, 2026

Weighted-average sale price $153.7014 per share Sale of 1,100 shares on November 2, 2026

Key Terms

weighted average price, non-derivative, direct

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

non-derivative technical

"Common Stock; non-derivative sale"

direct technical

"Direct ownership of Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CROX shares did director Douglas J. Treff sell?

Douglas J. Treff reported sales totaling 14,802 shares on November 2, 2026, across four transactions: 3,416 shares, 3,101 shares, 7,185 shares, and 1,100 shares.

What price ranges applied to Douglas J. Treff’s CROX sales?

The reported weighted-average prices were $150.7006, $151.8064, $152.8515, and $153.7014 per share. The respective transaction-price ranges were $150.26–$151.19, $151.31–$152.24, $152.43–$153.25, and $153.63–$153.85.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TREFF DOUGLAS J

(Last)

(First)

(Middle)

C/O CROCS, INC.

500 ELDORADO BLVD #5

(Street)

BROOMFIELD

COLORADO

80021

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/02/2026		S		3,416	D	$150.7006⁽¹⁾	83,471	D
Common Stock	11/02/2026		S		3,101	D	$151.8064⁽²⁾	80,370	D
Common Stock	11/02/2026		S		7,185	D	$152.8515⁽³⁾	73,185	D
Common Stock	11/02/2026		S		1,100	D	$153.7014⁽⁴⁾	72,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.26 - $151.19, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.31 to $152.24, inclusive.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.43 to $153.25, inclusive

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.63 to $153.85, inclusive.

Remarks:

	/s/Sara Hoverstock, Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR